Invention Grant
- Patent Title: Quinoline derivatives as PI3 kinase inhibitors
- Patent Title (中): 喹啉衍生物作为PI3激酶抑制剂
-
Application No.: US13411887Application Date: 2012-03-05
-
Publication No.: US08633187B2Publication Date: 2014-01-21
- Inventor: Steven David Knight , Stanley J. Schmidt
- Applicant: Steven David Knight , Stanley J. Schmidt
- Applicant Address: US PA Philadelphia
- Assignee: GlaxoSmithKline LLC
- Current Assignee: GlaxoSmithKline LLC
- Current Assignee Address: US PA Philadelphia
- Agent Duke M. Fitch; Kathryn A. Lutomski; John Lemanowicz
- Main IPC: A61K31/4709
- IPC: A61K31/4709 ; A61K31/5383 ; A61K31/5377 ; A61K31/549
Abstract:
Invented is a method of inhibiting the activity/function of PI3 kinases using quinoline derivatives. Also invented is a method of treating one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, cancer, sperm motility, transplantation rejection, graft rejection and lung injuries by the administration of quinoline derivatives.
Public/Granted literature
- US20120165321A1 QUINOLINE DERIVATIVES AS PI3 KINASE INHIBITORS Public/Granted day:2012-06-28
Information query
IPC分类:
